Your browser doesn't support javascript.
loading
Reprogramming human urine cells into intestinal organoids with long-term expansion ability and barrier function.
Zhang, Ruifang; Chen, Yating; Feng, Ziyu; Cai, Baomei; Cheng, Yiyi; Du, Yunjing; Ou, Sihua; Chen, Huan; Pan, Mengjie; Liu, He; Pei, Duanqing; Cao, Shangtao.
Afiliação
  • Zhang R; Key Laboratory of Biological Targeting Diagnosis, Therapy, and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Chen Y; Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou, Guangdong, China.
  • Feng Z; Key Laboratory of Biological Targeting Diagnosis, Therapy, and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Cai B; Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou, Guangdong, China.
  • Cheng Y; Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou, Guangdong, China.
  • Du Y; Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou, Guangdong, China.
  • Ou S; Key Laboratory of Biological Targeting Diagnosis, Therapy, and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Chen H; School of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
  • Pan M; Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou, Guangdong, China.
  • Liu H; Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou, Guangdong, China.
  • Pei D; Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou, Guangdong, China.
  • Cao S; Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, Guangdong, China.
Heliyon ; 10(13): e33736, 2024 Jul 15.
Article em En | MEDLINE | ID: mdl-39040281
ABSTRACT
Generation of intestinal organoids from human somatic cells by reprogramming would enable intestinal regeneration, disease modeling, and drug screening in a personalized pattern. Here, we report a direct reprogramming protocol for the generation of human urine cells induced intestinal organoids (U-iIOs) under a defined medium. U-iIOs expressed multiple intestinal specific genes and showed resembling gene expression profiles to primary small intestines. U-iIOs can be stably long-term expanded and further differentiated into more mature intestinal lineage cells with high expression of metallothionein and cytochrome P450 (CYP450) genes. These specific molecular features of U-iIOs differ from human pluripotent stem cells derived intestinal organoids (P-iIOs) and intestinal immortalized cell lines. Furthermore, U-iIOs exhibit intestinal barriers indicated by blocking FITC-dextran permeation and uptaking of the specific substrate rhodamine 123. Our study provides a novel platform for patient-specific intestinal organoid generation, which may lead to precision treatment of intestinal diseases and facilitate drug discovery.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article